Covestor’s iShares Biotechnology ETF IBB Stock Holding History

Covestor’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Buy	4 +1	+33%	+$172	﹤0.01%	2193
2026 Q1	$1K	Sell	3 -1	-25%	-$171	﹤0.01%	2057
2025 Q4	$1K	Hold	4	–	–	﹤0.01%	2075
2025 Q3	$1K	Hold	4	–	–	﹤0.01%	2096
2025 Q2	$1K	Buy	+4	New	+$491	﹤0.01%	2012
2024 Q1	–	Sell	-4	Closed	-$546	–	2455
2023 Q4	$1K	Buy	+4	New	+$488	﹤0.01%	1979
2023 Q3	–	Sell	-11	Closed	-$1K	–	2362
2023 Q2	$1K	Sell	11 -2	-15%	-$260	﹤0.01%	1959
2023 Q1	$2K	Hold	13	–	–	﹤0.01%	1757
2022 Q4	$2K	Hold	13	–	–	﹤0.01%	1778
2022 Q3	$2K	Hold	13	–	–	﹤0.01%	1712
2022 Q2	$2K	Hold	13	–	–	﹤0.01%	1614
2022 Q1	$2K	Sell	13 -10	-43%	-$1.3K	﹤0.01%	1674
2021 Q4	$4K	Buy	+23	New	+$3.56K	0.01%	1394

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Covestor's IBB Position: Q2 2026 in Review

Covestor increased its iShares Biotechnology ETF (IBB) stake by 33% in Q2 2026, buying an estimated $172 and bringing the position to 4 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2193.

Covestor first reported a position in IBB in Q4 2021 and has held it in 13 quarters since. The position peaked at $4K in Q4 2021. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Covestor held 4 shares of iShares Biotechnology ETF worth $1K as of Q2 2026.
Covestor bought 1 iShares Biotechnology ETF share in Q2 2026, an estimated $172.
iShares Biotechnology ETF made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2193 holding.
Covestor first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 13 quarters since.
Covestor's iShares Biotechnology ETF position peaked at $4K in Q4 2021.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.